Mirae Asset Global Investments Co. Ltd. Increases Stock Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Mirae Asset Global Investments Co. Ltd. grew its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 25.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 12,341 shares of the real estate investment trust’s stock after purchasing an additional 2,526 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Omega Healthcare Investors were worth $498,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in OHI. Versant Capital Management Inc purchased a new position in Omega Healthcare Investors during the 2nd quarter worth approximately $26,000. UMB Bank n.a. grew its position in shares of Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 516 shares during the last quarter. DiNuzzo Private Wealth Inc. acquired a new position in shares of Omega Healthcare Investors in the 3rd quarter valued at $33,000. V Square Quantitative Management LLC raised its position in Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after purchasing an additional 323 shares during the last quarter. Finally, Covestor Ltd boosted its stake in Omega Healthcare Investors by 47.6% during the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock worth $42,000 after purchasing an additional 431 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 3.0 %

Shares of OHI stock opened at $41.20 on Friday. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 5.79. The business’s fifty day moving average price is $40.47 and its 200 day moving average price is $36.00. The firm has a market capitalization of $10.62 billion, a PE ratio of 30.29, a P/E/G ratio of 1.37 and a beta of 0.99.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The company had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. Omega Healthcare Investors had a net margin of 34.41% and a return on equity of 8.83%. The business’s revenue for the quarter was up 17.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.74 EPS. As a group, sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.50%. The ex-dividend date is Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on OHI shares. Truist Financial upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their price objective for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research note on Thursday. Wells Fargo & Company restated an “overweight” rating and set a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Finally, BMO Capital Markets lifted their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $39.70.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.